Literature DB >> 33089325

Radiotherapy innovations to optimize brain metastases control.

Vinai Gondi1, Minesh P Mehta2.   

Abstract

Entities:  

Keywords:  brain metastases; hippocampal avoidance; whole-brain radiotherapy

Year:  2020        PMID： 33089325      PMCID： PMC7746921          DOI： 10.1093/neuonc/noaa244

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN： 1522-8517            Impact factor:   12.300


× No keyword cloud information.
  13 in total

1.  Stereotactic radiosurgery plus whole-brain radiation therapy vs stereotactic radiosurgery alone for treatment of brain metastases: a randomized controlled trial.

Authors:  Hidefumi Aoyama; Hiroki Shirato; Masao Tago; Keiichi Nakagawa; Tatsuya Toyoda; Kazuo Hatano; Masahiro Kenjyo; Natsuo Oya; Saeko Hirota; Hiroki Shioura; Etsuo Kunieda; Taisuke Inomata; Kazushige Hayakawa; Norio Katoh; Gen Kobashi
Journal:  JAMA       Date:  2006-06-07       Impact factor: 56.272

2.  Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952-26001 study.

Authors:  Martin Kocher; Riccardo Soffietti; Ufuk Abacioglu; Salvador Villà; Francois Fauchon; Brigitta G Baumert; Laura Fariselli; Tzahala Tzuk-Shina; Rolf-Dieter Kortmann; Christian Carrie; Mohamed Ben Hassel; Mauri Kouri; Egils Valeinis; Dirk van den Berge; Sandra Collette; Laurence Collette; Rolf-Peter Mueller
Journal:  J Clin Oncol       Date:  2010-11-01       Impact factor: 44.544

3.  Phase II trial of hippocampal-sparing whole brain irradiation with simultaneous integrated boost for metastatic cancer.

Authors:  Kenneth D Westover; J Travis Mendel; Tu Dan; Kiran Kumar; Ang Gao; Suprabha Pulipparacharuv; Puneeth Iyengar; Lucien Nedzi; Raquibul Hannan; John Anderson; Kevin S Choe; Wen Jiang; Ramzi Abdulrahman; Asal Rahimi; Michael Folkert; Aaron Laine; Chase Presley; C Munro Cullum; Hak Choy; Chul Ahn; Robert Timmerman
Journal:  Neuro Oncol       Date:  2020-12-18       Impact factor: 12.300

4.  Memantine for the prevention of cognitive dysfunction in patients receiving whole-brain radiotherapy: a randomized, double-blind, placebo-controlled trial.

Authors:  Paul D Brown; Stephanie Pugh; Nadia N Laack; Jeffrey S Wefel; Deepak Khuntia; Christina Meyers; Ali Choucair; Sherry Fox; John H Suh; David Roberge; Vivek Kavadi; Soren M Bentzen; Minesh P Mehta; Deborah Watkins-Bruner
Journal:  Neuro Oncol       Date:  2013-08-16       Impact factor: 12.300

5.  Whole brain radiation therapy with or without stereotactic radiosurgery boost for patients with one to three brain metastases: phase III results of the RTOG 9508 randomised trial.

Authors:  David W Andrews; Charles B Scott; Paul W Sperduto; Adam E Flanders; Laurie E Gaspar; Michael C Schell; Maria Werner-Wasik; William Demas; Janice Ryu; Jean-Paul Bahary; Luis Souhami; Marvin Rotman; Minesh P Mehta; Walter J Curran
Journal:  Lancet       Date:  2004-05-22       Impact factor: 79.321

6.  Hippocampus-avoidance whole-brain radiation therapy with a simultaneous integrated boost for multiple brain metastases.

Authors:  Ilinca Popp; Stephan Rau; Mandy Hintz; Julius Schneider; Angelika Bilger; Jamina Tara Fennell; Dieter Henrik Heiland; Thomas Rothe; Karl Egger; Carsten Nieder; Horst Urbach; Anca Ligia Grosu
Journal:  Cancer       Date:  2020-03-06       Impact factor: 6.860

7.  Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial.

Authors:  Eric L Chang; Jeffrey S Wefel; Kenneth R Hess; Pamela K Allen; Frederick F Lang; David G Kornguth; Rebecca B Arbuckle; J Michael Swint; Almon S Shiu; Moshe H Maor; Christina A Meyers
Journal:  Lancet Oncol       Date:  2009-10-02       Impact factor: 41.316

8.  Hippocampal Avoidance During Whole-Brain Radiotherapy Plus Memantine for Patients With Brain Metastases: Phase III Trial NRG Oncology CC001.

Authors:  Paul D Brown; Vinai Gondi; Stephanie Pugh; Wolfgang A Tome; Jeffrey S Wefel; Terri S Armstrong; Joseph A Bovi; Cliff Robinson; Andre Konski; Deepak Khuntia; David Grosshans; Tammie L S Benzinger; Deborah Bruner; Mark R Gilbert; David Roberge; Vijayananda Kundapur; Kiran Devisetty; Sunjay Shah; Kenneth Usuki; Bethany Marie Anderson; Baldassarre Stea; Harold Yoon; Jing Li; Nadia N Laack; Tim J Kruser; Steven J Chmura; Wenyin Shi; Snehal Deshmukh; Minesh P Mehta; Lisa A Kachnic
Journal:  J Clin Oncol       Date:  2020-02-14       Impact factor: 50.717

9.  Repeated Courses of Radiosurgery for New Brain Metastases to Defer Whole Brain Radiotherapy: Feasibility and Outcome With Validation of the New Prognostic Metric Brain Metastasis Velocity.

Authors:  Corinna Fritz; Kim Borsky; Luisa S Stark; S Tanadini-Lang; Stephanie G C Kroeze; Jérôme Krayenbühl; Matthias Guckenberger; Nicolaus Andratschke
Journal:  Front Oncol       Date:  2018-11-22       Impact factor: 6.244

10.  Whole-brain irradiation with hippocampal sparing and dose escalation on metastases: neurocognitive testing and biological imaging (HIPPORAD) - a phase II prospective randomized multicenter trial (NOA-14, ARO 2015-3, DKTK-ROG).

Authors:  Anca-Ligia Grosu; Lars Frings; Iryna Bentsalo; Oliver Oehlke; Franziska Brenner; Angelika Bilger; Jamina Tara Fennell; Thomas Rothe; Sabine Schneider-Fuchs; Erika Graf; Claudia Schmoor; Jürgen Beck; Gerhild Becker; Michael Bock; Karl Egger; Horst Urbach; Claas Lahmann; Ilinca Popp
Journal:  BMC Cancer       Date:  2020-06-08       Impact factor: 4.430
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.